MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

Title
MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
Authors
Keywords
-
Journal
BLOOD
Volume -, Issue -, Pages -
Publisher
American Society of Hematology
Online
2020-06-25
DOI
10.1182/blood.2020005795

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started